There are multiple definitions:
tumor mutational burden(English)
- an emerging biomarker for response to PD-1/PD-L1 inhibitors. The evaluation is based on the hypothesis that a high number of mutations in somatic exonic regions will lead to an increase in neoantigen production, which could then be recognised by CD8+ T cells, resulting in improved immune responses
- PD-1, TMM, SHCBP1, NSCLC, PD-L1, SRRM, CXCL13, GDSC, HRD, FN1, IPS, PLAUR, TCIA, TIDE, TMB, SDC-1
- Biomarker, Oncology, Immunology
- https://doi.org…jca.2020.02.038
- https://doi.org…sbj.2022.06.039
- https://doi.org…967-024-04904-6
- https://doi.org…946320241249395
traumatic microbleed(English)
- does not seem to be a significant prognostic factor of RTW
- CARE, mTBI, PAR, PCS, RPQ, RTW, TBI
- Post-traumatic state, Prognosis, Injury, Brain (dys)function
- https://doi.org…9/neu.2021.0055
trail making (part) B(English)
- commonly used as a brief and simple neuropsychological assessment of executive dysfunction. It is thought to rely on a number of distinct cognitive processes that predict individual differences in performance
- DSST, HbA1C, T1DM, VCD, 4CRT
- Brain (dys)function, Cognitive function, Diabetes, Alcohol
- https://doi.org…ell.2019.04.001
- https://doi.org…91.2004.01154.x
tetramethylbenzidine(English)
- refers to a tissue processing method for studying neuronal connections at the electron microscopic level
- Brain (dys)function, Microscopy, Histochemistry
- https://doi.org…2/cne.902260104
- https://doi.org…0270(88)90136-7